Literature DB >> 28640657

Retinal Findings on OCT in Systemic Conditions.

Preeti Patil Chhablani1, Vikas Ambiya1, Akshay G Nair1, Sailaja Bondalapati2, Jay Chhablani1.   

Abstract

PURPOSE: Imaging technology has advanced by leaps and bounds in the recent past and has resulted in a much greater understanding of ocular diseases. The aim of this review article is to summarize optical coherence tomography (OCT) findings of various systemic conditions.
METHOD: A systematic literature search of the Medline/PubMed database was performed. English articles up to April 2015 were included. Terms used for search included: Alzheimer's Disease; Multiple Sclerosis; Parkinson's Disease; Behçet's Disease; Schizophrenia; Migraine; Obstructive Sleep Apnea Syndrome; Neurofibromatosis; Sickle Cell Disease; Renal diseases; Lupus Retinopathy; Valsalva Retinopathy; Whiplash Retinopathy; Shaken-Baby Syndrome; Choroidal metastases; Intracranial Hypertension; Drug toxicity; Deferoxamine; Sildenafil; Tamoxifen; Hydroxychloroquine; Chloroquine; Ethambutol; Lead; Sickle Cell Disease; and Thalassemia along with OCT.
RESULTS: Studies have shown that inner retinal thinning could be the earliest sign of neurological diseases and may help to differentiate individuals with abnormalities. Outer retinal damage was noted in cancer-related retinopathy and secondary to drug toxicity as a diagnostic sign. This review article summarizes the OCT findings and their importance in early diagnosis, treatment, and follow-up in a varying spectrum of systemic diseases including neurological diseases, hematological diseases, cancer-related retinopathies, and systemic drug toxicity.
CONCLUSION: OCT findings are useful to predict the probability of a disease, to diagnose it early, to differentiate between healthy and unhealthy tissue, and to assess the effect of therapeutic interventions in many systemic diseases.

Entities:  

Keywords:  Alzheimer’s disease; Parkinson’s disease; Sickle Cell disease; leukemia; lupus retinopathy; migraine; multiple sclerosis; obstructive sleep apnea syndrome; schizophrenia; shaken-baby syndrome

Mesh:

Year:  2017        PMID: 28640657     DOI: 10.1080/08820538.2017.1332233

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  6 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  Retinal thickness and microvascular alterations in the diagnosis of systemic lupus erythematosus: a new approach.

Authors:  Ren Liu; Yan Wang; Qiang Xia; Tian Xu; Ting Han; Shuang Cai; Shui-Lin Luo; Rui Wu; Yi Shao
Journal:  Quant Imaging Med Surg       Date:  2022-01

3.  Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant Data.

Authors:  Charalampos T Kazakos; Vasilios Karageorgiou
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

4.  Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.

Authors:  Jing Jin; Vinay Kandula; Robin E Miller
Journal:  Pediatr Blood Cancer       Date:  2021-03-31       Impact factor: 3.838

5.  Oculomics - The eyes talk a great deal.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

Review 6.  Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.

Authors:  Stela Vujosevic; M Margarita Parra; M Elizabeth Hartnett; Louise O'Toole; Alessia Nuzzi; Celeste Limoli; Edoardo Villani; Paolo Nucci
Journal:  Eye (Lond)       Date:  2022-04-15       Impact factor: 4.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.